George V Migausky has an estimated net worth of $9.29 Million. This is based on reported shares across multiple companies, which include BIOVERIS CORP, REGENXBIO Inc., Immunovant, Inc., OCULAR THERAPEUTIX, INC, Dimension Therapeutics, Inc., ABEONA THERAPEUTICS INC., DYAX CORP, and IGEN INTERNATIONAL INC /DE.

2016 was George V Migausky's most active year for acquiring shares with 13 total transactions. George V Migausky's most active month to acquire stocks was the month of January. 2004 was George V Migausky's most active year for disposing of shares, totalling 27 transactions. George V Migausky's most active month to dispose stocks was the month of January. 2016 saw George V Migausky paying a total of $2,525,117.10 for 712,694 shares, this is the most they've acquired in one year. In 2007 George V Migausky cashed out on 456,025 shares for a total of $2,881,537.50, their largest year based on trade value.